-
Signature
-
/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening
-
Issuer symbol
-
(CALX)
-
Transactions as of
-
22 Jul 2025
-
Transactions value $
-
-$9,900,720
-
Form type
-
4
-
Filing time
-
24 Jul 2025, 18:42:46
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Weening Michael |
President & CEO, Director |
C/O CALIX, INC., 2777 ORCHARD PARKWAY, SAN JOSE |
/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening |
2025-07-24 |
0001678385 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$547K |
+92K |
+581.84% |
$5.95 |
108K |
22 Jul 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Sale |
-$5.06M |
-92K |
-85.33% |
$55.00 |
15.8K |
22 Jul 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$547K |
+92K |
+581.84% |
$5.95 |
108K |
23 Jul 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Sale |
-$5.15M |
-92K |
-85.33% |
$56.00 |
15.8K |
23 Jul 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$128K |
+16K |
+101.19% |
$8.03 |
31.8K |
23 Jul 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Sale |
-$912K |
-16K |
-50.3% |
$57.00 |
15.8K |
23 Jul 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-92K |
-50% |
$0.00 |
92K |
22 Jul 2025 |
Common Stock |
92K |
$5.95 |
Direct |
F1 |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-92K |
-100% |
$0.00 |
0 |
23 Jul 2025 |
Common Stock |
92K |
$5.95 |
Direct |
F1 |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-16K |
-17.78% |
$0.00 |
74K |
23 Jul 2025 |
Common Stock |
16K |
$8.03 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
Sales reported on the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.